RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $29,349 | -16.3% | 27,175 | 0.0% | 0.00% | – |
Q2 2023 | $35,056 | -2.3% | 27,175 | 0.0% | 0.00% | – |
Q1 2023 | $35,871 | -12.0% | 27,175 | 0.0% | 0.00% | – |
Q4 2022 | $40,763 | +23.5% | 27,175 | -4.0% | 0.00% | – |
Q3 2022 | $33,000 | -19.5% | 28,305 | -21.3% | 0.00% | – |
Q2 2022 | $41,000 | -62.0% | 35,988 | 0.0% | 0.00% | – |
Q1 2022 | $108,000 | +13.7% | 35,988 | 0.0% | 0.00% | – |
Q4 2021 | $95,000 | +2.2% | 35,988 | +40.8% | 0.00% | – |
Q3 2021 | $93,000 | +32.9% | 25,568 | +58.9% | 0.00% | – |
Q2 2021 | $70,000 | +180.0% | 16,088 | +39.9% | 0.00% | – |
Q4 2019 | $25,000 | +13.6% | 11,500 | 0.0% | 0.00% | – |
Q3 2019 | $22,000 | -26.7% | 11,500 | 0.0% | 0.00% | – |
Q2 2019 | $30,000 | -14.3% | 11,500 | -14.8% | 0.00% | – |
Q1 2019 | $35,000 | +12.9% | 13,500 | 0.0% | 0.00% | – |
Q4 2018 | $31,000 | -16.2% | 13,500 | +17.4% | 0.00% | – |
Q3 2018 | $37,000 | +12.1% | 11,500 | 0.0% | 0.00% | – |
Q2 2018 | $33,000 | – | 11,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 1,847,087 | $4,119,000 | 3.26% |
Sio Capital Management, LLC | 1,333,696 | $2,974,000 | 1.52% |
Boxer Capital, LLC | 700,000 | $1,561,000 | 1.38% |
Palo Alto Investors LP | 5,386,534 | $12,012,000 | 0.91% |
ACUTA CAPITAL PARTNERS, LLC | 747,748 | $1,667,000 | 0.80% |
SENZAR ASSET MANAGEMENT, LLC | 1,443,003 | $3,217,897,000 | 0.70% |
Ghost Tree Capital, LLC | 800,000 | $1,784,000 | 0.52% |
NEA Management Company, LLC | 3,243,150 | $7,232,000 | 0.38% |
Rhenman & Partners Asset Management AB | 850,000 | $1,896,000 | 0.34% |
Rock Springs Capital Management LP | 1,750,000 | $3,903,000 | 0.29% |